Association of genome-wide variation with the risk of incident heart failure in adults of European and African ancestry: A prospective meta-analysis from the cohorts for heart and aging research in genomic epidemiology (CHARGE) consortium

Nicholas L. Smith, Janine F. Felix, Alanna C. Morrison, Serkalem Demissie, Nicole L. Glazer, Laura R. Loehr, L. Adrienne Cupples, Abbas Dehghan, Thomas Lumley, Wayne D. Rosamond, Wolfgang Lieb, Fernando Rivadeneira, Joshua C. Bis, Aaron R. Folsom, Emelia Benjamin, Yurii S. Aulchenko, Talin Haritunians, David Couper, Joanne Murabito, Ying A. WangBruno H. Stricker, John S. Gottdiener, Patricia P. Chang, Thomas J. Wang, Kenneth M. Rice, Albert Hofman, Susan R. Heckbert, Ervin R. Fox, Christopher J. O'Donnell, Andre G. Uitterlinden, Jerome I. Rotter, James T. Willerson, Daniel Levy, Cornelia M. Van Duijn, Bruce M. Psaty, Jacqueline C M Witteman, Eric Boerwinkle, Ramachandran S. Vasan

Research output: Contribution to journalArticlepeer-review

125 Scopus citations

Abstract

Background-Although genetic factors contribute to the onset of heart failure (HF), no large-scale genome-wide investigation of HF risk has been published to date. We have investigated the association of 2 478 304 single-nucleotide polymorphisms with incident HF by meta-analyzing data from 4 community-based prospective cohorts: the Atherosclerosis Risk in Communities Study, the Cardiovascular Health Study, the Framingham Heart Study, and the Rotterdam Study. Methods and Results-Eligible participants for these analyses were of European or African ancestry and free of clinical HF at baseline. Each study independently conducted genome-wide scans and imputed data to the ≈2.5 million single-nucleotide polymorphisms in HapMap. Within each study, Cox proportional hazards regression models provided age- and sex-adjusted estimates of the association between each variant and time to incident HF. Fixed-effect meta-analyses combined results for each single-nucleotide polymorphism from the 4 cohorts to produce an overall association estimate and P value. A genome-wide significance P value threshold was set a priori at 5.0×10-7. During a mean follow-up of 11.5 years, 2526 incident HF events (12%) occurred in 20 926 European-ancestry participants. The meta-analysis identified a genome-wide significant locus at chromosomal position 15q22 (1.4×10-8), which was 58.8 kb from USP3. Among 2895 African-ancestry participants, 466 incident HF events (16%) occurred during a mean follow-up of 13.7 years. One genome-wide significant locus was identified at 12q14 (6.7×10-8), which was 6.3 kb from LRIG3. Conclusions-We identified 2 loci that were associated with incident HF and exceeded genome-wide significance. The findings merit replication in other community-based settings of incident HF.

Original languageEnglish (US)
Pages (from-to)256-266
Number of pages11
JournalCirculation: Cardiovascular Genetics
Volume3
Issue number3
DOIs
StatePublished - Jun 2010

Keywords

  • Epidemiology
  • Genetics
  • Genome-wide variation
  • Heart failure
  • Incidence

Fingerprint Dive into the research topics of 'Association of genome-wide variation with the risk of incident heart failure in adults of European and African ancestry: A prospective meta-analysis from the cohorts for heart and aging research in genomic epidemiology (CHARGE) consortium'. Together they form a unique fingerprint.

Cite this